US Stock MarketDetailed Quotes

CNS Pharmaceuticals (CNSP)

Watchlist
  • 5.520
  • -0.600-9.80%
Close May 13 16:00 ET
  • 5.150
  • -0.370-6.70%
Pre 09:13 ET
4.48MMarket Cap-0.15P/E (TTM)

CNS Pharmaceuticals (CNSP) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
19.30%-13.81M
44.22%-3.05M
68.03%-2.17M
-223.76%-5.34M
-1.56%-3.24M
-21.03%-17.11M
-115.70%-5.47M
-101.40%-6.8M
51.50%-1.65M
33.84%-3.19M
Net income from continuing operations
-6.68%-15.85M
-87.50%-5.96M
42.59%-3.22M
6.16%-2.37M
-21.34%-4.3M
21.18%-14.86M
40.91%-3.18M
-23.95%-5.61M
37.07%-2.53M
28.13%-3.54M
Operating gains losses
1,446.84%2.56K
----
----
----
----
-138.15%-190
--0
--0
--0
---190
Depreciation and amortization
18.51%3.92K
3.55%1.02K
-7.19%697
46.41%1.1K
34.47%1.1K
-20.03%3.31K
3.36%985
-16.46%751
-25.02%752
-36.04%818
Other non cash items
----
----
----
----
----
--596.3K
--1
----
----
----
Change In working capital
149.95%1.85M
216.08%2.82M
149.70%1.03M
-563.57%-2.99M
567.84%995.95K
-199.86%-3.69M
-193.09%-2.43M
-317.13%-2.06M
96.85%645.26K
180.94%149.13K
-Change in prepaid assets
604.90%302.8K
260.87%961.82K
-27.10%401.66K
-1,350.83%-1.68M
505.05%623.16K
-102.52%-59.97K
-174.71%-597.9K
-26.92%550.99K
-188.70%-116.06K
-85.12%102.99K
-Change in payables and accrued expense
142.45%1.54M
199.04%1.81M
125.53%667.2K
-271.73%-1.31M
708.01%372.78K
-374.91%-3.63M
-201.23%-1.83M
-1,432.80%-2.61M
286.57%761.32K
105.26%46.14K
Cash from discontinued investing activities
Operating cash flow
19.30%-13.81M
44.22%-3.05M
68.03%-2.17M
-223.76%-5.34M
-1.56%-3.24M
-21.03%-17.11M
-115.70%-5.47M
-101.40%-6.8M
51.50%-1.65M
33.84%-3.19M
Investing cash flow
Cash flow from continuing investing activities
-333.98%-18.18K
-7.36%-4.19K
-94.16%-4.19K
Net PPE purchase and sale
-333.98%-18.18K
----
----
----
----
-7.36%-4.19K
-94.16%-4.19K
----
----
----
Cash from discontinued investing activities
Investing cash flow
-333.98%-18.18K
----
----
----
----
-7.36%-4.19K
-94.16%-4.19K
----
----
----
Financing cash flow
Cash flow from continuing financing activities
-36.74%14.57M
-91.80%406.87K
-100.75%-91.62K
90.20%4.43M
184.17%9.83M
396.63%23.03M
127.92%4.96M
146,826.13%12.28M
-9.52%2.33M
2,975.33%3.46M
Net issuance payments of debt
1.08%-297.55K
1.27%-30.79K
1.18%-90.97K
1.06%-88.91K
0.93%-86.88K
31.44%-300.81K
55.87%-31.19K
26.05%-92.06K
26.76%-89.86K
27.45%-87.7K
Net common stock issuance
-39.92%14.04M
-89.97%501.75K
-100.01%-1.49K
86.09%4.51M
155.60%9.03M
908.65%23.38M
2,220.75%5M
9,244.01%12.41M
23.12%2.42M
--3.53M
Proceeds from stock option exercised by employees
-82.99%3.63K
--0
--844
-68.80%2.78K
--0
-99.28%21.33K
-100.00%-1
--0
-98.77%8.92K
1,936.95%12.41K
Net other financing activities
1,326.15%818.46K
-540.82%-64.08K
--0
--0
--882.54K
67.10%-66.75K
---10K
---40K
----
----
Cash from discontinued financing activities
Financing cash flow
-36.74%14.57M
-91.80%406.87K
-100.75%-91.62K
90.20%4.43M
184.17%9.83M
396.63%23.03M
127.92%4.96M
146,826.13%12.28M
-9.52%2.33M
2,975.33%3.46M
Net cash flow
Beginning cash position
1,077.53%6.46M
41.46%9.86M
713.23%12.13M
1,500.49%13.05M
1,077.53%6.46M
-94.54%548.72K
666.66%6.97M
-65.14%1.49M
-84.05%815.23K
-94.54%548.72K
Current changes in cash
-87.49%739.64K
-420.39%-2.66M
-141.33%-2.27M
-235.69%-917.72K
2,371.33%6.59M
162.19%5.91M
-41.83%-511.75K
262.67%5.48M
181.36%676.33K
105.39%266.51K
End cash Position
11.45%7.2M
11.45%7.2M
41.46%9.86M
713.23%12.13M
1,500.49%13.05M
1,077.53%6.46M
1,077.53%6.46M
666.66%6.97M
-65.14%1.49M
-84.05%815.23K
Free cash flow
19.21%-13.83M
43.93%-3.07M
68.03%-2.17M
-223.76%-5.34M
-1.56%-3.24M
-21.02%-17.12M
-115.68%-5.48M
-101.30%-6.8M
51.50%-1.65M
33.84%-3.19M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 19.30%-13.81M44.22%-3.05M68.03%-2.17M-223.76%-5.34M-1.56%-3.24M-21.03%-17.11M-115.70%-5.47M-101.40%-6.8M51.50%-1.65M33.84%-3.19M
Net income from continuing operations -6.68%-15.85M-87.50%-5.96M42.59%-3.22M6.16%-2.37M-21.34%-4.3M21.18%-14.86M40.91%-3.18M-23.95%-5.61M37.07%-2.53M28.13%-3.54M
Operating gains losses 1,446.84%2.56K-----------------138.15%-190--0--0--0---190
Depreciation and amortization 18.51%3.92K3.55%1.02K-7.19%69746.41%1.1K34.47%1.1K-20.03%3.31K3.36%985-16.46%751-25.02%752-36.04%818
Other non cash items ----------------------596.3K--1------------
Change In working capital 149.95%1.85M216.08%2.82M149.70%1.03M-563.57%-2.99M567.84%995.95K-199.86%-3.69M-193.09%-2.43M-317.13%-2.06M96.85%645.26K180.94%149.13K
-Change in prepaid assets 604.90%302.8K260.87%961.82K-27.10%401.66K-1,350.83%-1.68M505.05%623.16K-102.52%-59.97K-174.71%-597.9K-26.92%550.99K-188.70%-116.06K-85.12%102.99K
-Change in payables and accrued expense 142.45%1.54M199.04%1.81M125.53%667.2K-271.73%-1.31M708.01%372.78K-374.91%-3.63M-201.23%-1.83M-1,432.80%-2.61M286.57%761.32K105.26%46.14K
Cash from discontinued investing activities
Operating cash flow 19.30%-13.81M44.22%-3.05M68.03%-2.17M-223.76%-5.34M-1.56%-3.24M-21.03%-17.11M-115.70%-5.47M-101.40%-6.8M51.50%-1.65M33.84%-3.19M
Investing cash flow
Cash flow from continuing investing activities -333.98%-18.18K-7.36%-4.19K-94.16%-4.19K
Net PPE purchase and sale -333.98%-18.18K-----------------7.36%-4.19K-94.16%-4.19K------------
Cash from discontinued investing activities
Investing cash flow -333.98%-18.18K-----------------7.36%-4.19K-94.16%-4.19K------------
Financing cash flow
Cash flow from continuing financing activities -36.74%14.57M-91.80%406.87K-100.75%-91.62K90.20%4.43M184.17%9.83M396.63%23.03M127.92%4.96M146,826.13%12.28M-9.52%2.33M2,975.33%3.46M
Net issuance payments of debt 1.08%-297.55K1.27%-30.79K1.18%-90.97K1.06%-88.91K0.93%-86.88K31.44%-300.81K55.87%-31.19K26.05%-92.06K26.76%-89.86K27.45%-87.7K
Net common stock issuance -39.92%14.04M-89.97%501.75K-100.01%-1.49K86.09%4.51M155.60%9.03M908.65%23.38M2,220.75%5M9,244.01%12.41M23.12%2.42M--3.53M
Proceeds from stock option exercised by employees -82.99%3.63K--0--844-68.80%2.78K--0-99.28%21.33K-100.00%-1--0-98.77%8.92K1,936.95%12.41K
Net other financing activities 1,326.15%818.46K-540.82%-64.08K--0--0--882.54K67.10%-66.75K---10K---40K--------
Cash from discontinued financing activities
Financing cash flow -36.74%14.57M-91.80%406.87K-100.75%-91.62K90.20%4.43M184.17%9.83M396.63%23.03M127.92%4.96M146,826.13%12.28M-9.52%2.33M2,975.33%3.46M
Net cash flow
Beginning cash position 1,077.53%6.46M41.46%9.86M713.23%12.13M1,500.49%13.05M1,077.53%6.46M-94.54%548.72K666.66%6.97M-65.14%1.49M-84.05%815.23K-94.54%548.72K
Current changes in cash -87.49%739.64K-420.39%-2.66M-141.33%-2.27M-235.69%-917.72K2,371.33%6.59M162.19%5.91M-41.83%-511.75K262.67%5.48M181.36%676.33K105.39%266.51K
End cash Position 11.45%7.2M11.45%7.2M41.46%9.86M713.23%12.13M1,500.49%13.05M1,077.53%6.46M1,077.53%6.46M666.66%6.97M-65.14%1.49M-84.05%815.23K
Free cash flow 19.21%-13.83M43.93%-3.07M68.03%-2.17M-223.76%-5.34M-1.56%-3.24M-21.02%-17.12M-115.68%-5.48M-101.30%-6.8M51.50%-1.65M33.84%-3.19M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More